Fact CheckerSign in

NCT06471504Recruiting

Use of Eye Tracking to Aid in Autism Risk Detection

Source: ClinicalTrials.gov · Last updated 22 Apr 2026

Brief summary (registry, in English)

The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
100 (estimated)
First submitted
24 May 2024
Start date
8 Jan 2025
Primary completion date
30 Apr 2027
Lead sponsor
Indiana University
Diseases
Autism
NCT number
NCT06471504

What you commit to

  • Study type: Interventional
  • Planned participants: 100
  • From 8 Jan 2025 to the primary completion date, 30 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Child is younger than 12 months or older than 48 months.

Other

  • Child's caregiver(s) is not English- or Spanish-speaking.

Who the study is looking for

  • Young children ages 12-48 months scheduled for health care visits at Riley Hospital for Children at Indiana University Health clinics (e.g., Pediatric Care Center clinics).
  • Children must have English- or Spanish-speaking caregivers.
  • Children must have a legal guardian that is able to provide consent.

Age in the registry: 12 months to 48 months · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Riley Hospital for Children
Coordinator of this site? Confirm its status
IndianapolisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.